Clinical Corner
Share

August 11, 2026

Arborstone Enhanced Care

Arborstone Enhanced Care, Halifax, N.S., has been recognized nationally for excellence in the Appropriate Use of Antipsychotics. One of only 32 long term care communities across Canada to meet this standard, Arborstone is the only home in Nova Scotia to receive this recognition.

This achievement reflects a strong commitment to compassionate, person-centred care and evidence-informed prescribing practices that prioritize resident safety, dignity, and quality of life. Nationally, many long term care residents continue to receive antipsychotic medications without a diagnosis of psychosis, despite the associated risks.

“Being recognized for our work in the appropriate use of antipsychotics is an important milestone for us at Arborstone,” says Gabby Gaspar-Lidstone, General Manager. “It reinforces our focus on compassionate, individualized care, and our dedication to continuously improving practices that support resident wellbeing.”

This recognition highlights the leadership and clinical excellence demonstrated by the Arborstone team, alongside Dr. Lewis, Dr. Olabisi, Dr. Raju, and Dr. Couture, in supporting safer medication practices.

Back row: Bee Ann Fradejas, Kuljit Kaur, Mary Ann Castaneda, Gabby Gaspar-Lidstone (me), Jamienn Lara Cornelia, Rowena Ochoco, Krissa Rabaya, Ethel Vila, and Gran Quijano Front row: Mitchel Lumaque, Julivel Layno, Heneylyn Rostata, and Stephanie Castanares

Back

Related News